Affimed N.V. (AFMD) Social Stream



Affimed N.V. (AFMD): $3.16

-0.10 (-3.07%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AFMD to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Affimed NV (AFMD) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Affimed NV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-21 5 $15 $10 $12.2 $4.4 177.27%
2021-11-11 5 $15 $10 $12 $4.4 172.73%
2022-01-12 5 $15 $11 $12.4 $4.4 181.82%
2022-02-23 6 $12 $11 $11.8 $4.4 168.18%

The Trend in the Analyst Price Target


AFMD's average price target has moved up $6.08 over the prior 21 months.

Over the past 47 weeks, AFMD's average upside potential has been 112.52%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-19 5 18.21680 13.15652 15.18047 5.54 174.02%
2021-08-19 5 18.09043 13.06526 15.07516 5.54 172.11%
2021-09-19 5 17.84285 11.89531 14.61645 6.39 128.74%
2021-09-20 5 17.61371 11.74255 14.42875 6.30 129.03%
2021-09-20 5 17.73971 11.82655 14.53196 6.30 130.67%

AFMD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 153 days, AFMD's average broker recommendation rating improved by 0.5.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Affimed NV's average analyst price target is greater than 58.57% of all US stocks.
  • AFMD has a higher upside potential (average analyst target price relative to current price) than 429.36% of all US stocks.
  • AFMD has a lower variance in analysts' estimates than -28.24% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Affimed NV's number of analysts covering the stock is greater than 348.1% of them.

In the Pharmaceutical Products industry, AEZS, ADXS, and ADAG are the three stocks most similar to Affimed NV regarding the price target and analyst recommendation information presented here.

Is AFMD a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4727 seconds.